These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1884556)

  • 1. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 1991 Sep; (270):4-7. PubMed ID: 1884556
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
    Mir O; Ropert S; Goldwasser F
    Lancet Oncol; 2008 Dec; 9(12):1198. PubMed ID: 19038767
    [No Abstract]   [Full Text] [Related]  

  • 3. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
    Sauer H; Wilmanns W
    Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
    Jaffe N; Frei E; Watts H; Traggis D
    Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
    Jaffe N
    Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery.
    Rosen G; Huvos AG; Mosende C; Beattie EJ; Exelby PR; Capparos B; Marcove RC
    Cancer; 1978 Mar; 41(3):841-9. PubMed ID: 305817
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in osteogenic sarcoma.
    Tichler TE; Am YB; Brenner HJ
    Prog Clin Biol Res; 1982; 99():49-75. PubMed ID: 6983080
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
    Jaffe N
    Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 14. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the chemotherapy of metastatic osteogenic sarcoma.
    Jaffe N
    Cancer; 1972 Dec; 30(6):1627-31. PubMed ID: 4539306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of high-dose methotrexate in patients with unresectable metastatic osteosarcoma.
    Edmonson JH; Creagan ET; Gilchrist GS
    Cancer Treat Rep; 1981; 65(5-6):538-9. PubMed ID: 6972255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.